nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1B—telencephalic ventricle—Alzheimer's disease	0.0496	0.122	CbGeAlD
Xylometazoline—HTR1D—telencephalic ventricle—Alzheimer's disease	0.048	0.118	CbGeAlD
Xylometazoline—HTR1B—blood vessel—Alzheimer's disease	0.0245	0.0602	CbGeAlD
Xylometazoline—HTR1D—blood vessel—Alzheimer's disease	0.0238	0.0582	CbGeAlD
Xylometazoline—ADRA1D—forebrain—Alzheimer's disease	0.0168	0.0411	CbGeAlD
Xylometazoline—ADRA1D—telencephalon—Alzheimer's disease	0.0154	0.0378	CbGeAlD
Xylometazoline—HTR1B—forebrain—Alzheimer's disease	0.0129	0.0317	CbGeAlD
Xylometazoline—HTR1D—forebrain—Alzheimer's disease	0.0125	0.0307	CbGeAlD
Xylometazoline—HTR1B—telencephalon—Alzheimer's disease	0.0119	0.0292	CbGeAlD
Xylometazoline—Oxymetazoline—HTR2A—Alzheimer's disease	0.0118	1	CrCbGaD
Xylometazoline—HTR1D—telencephalon—Alzheimer's disease	0.0115	0.0283	CbGeAlD
Xylometazoline—ADRA1A—forebrain—Alzheimer's disease	0.00963	0.0236	CbGeAlD
Xylometazoline—ADRA1B—nervous system—Alzheimer's disease	0.0093	0.0228	CbGeAlD
Xylometazoline—ADRA1D—nervous system—Alzheimer's disease	0.0091	0.0223	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—Alzheimer's disease	0.00896	0.022	CbGeAlD
Xylometazoline—ADRA1A—telencephalon—Alzheimer's disease	0.00885	0.0217	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—Alzheimer's disease	0.00876	0.0215	CbGeAlD
Xylometazoline—ADRA2C—telencephalon—Alzheimer's disease	0.00844	0.0207	CbGeAlD
Xylometazoline—ADRA2A—forebrain—Alzheimer's disease	0.00732	0.018	CbGeAlD
Xylometazoline—ADRA1B—brain—Alzheimer's disease	0.00711	0.0174	CbGeAlD
Xylometazoline—HTR1B—nervous system—Alzheimer's disease	0.00703	0.0172	CbGeAlD
Xylometazoline—ADRA1D—brain—Alzheimer's disease	0.00696	0.0171	CbGeAlD
Xylometazoline—HTR1D—nervous system—Alzheimer's disease	0.0068	0.0167	CbGeAlD
Xylometazoline—HTR1B—central nervous system—Alzheimer's disease	0.00676	0.0166	CbGeAlD
Xylometazoline—ADRA2A—telencephalon—Alzheimer's disease	0.00673	0.0165	CbGeAlD
Xylometazoline—HTR1D—central nervous system—Alzheimer's disease	0.00655	0.0161	CbGeAlD
Xylometazoline—HTR1B—brain—Alzheimer's disease	0.00537	0.0132	CbGeAlD
Xylometazoline—ADRA1A—nervous system—Alzheimer's disease	0.00523	0.0128	CbGeAlD
Xylometazoline—HTR1D—brain—Alzheimer's disease	0.0052	0.0128	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—Alzheimer's disease	0.00503	0.0123	CbGeAlD
Xylometazoline—ADRA2C—nervous system—Alzheimer's disease	0.00498	0.0122	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—Alzheimer's disease	0.00492	0.0121	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—Alzheimer's disease	0.0048	0.0118	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—Alzheimer's disease	0.00469	0.0115	CbGeAlD
Xylometazoline—ADRA1A—brain—Alzheimer's disease	0.004	0.0098	CbGeAlD
Xylometazoline—ADRA2A—nervous system—Alzheimer's disease	0.00397	0.00975	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—Alzheimer's disease	0.00383	0.00938	CbGeAlD
Xylometazoline—ADRA2C—brain—Alzheimer's disease	0.00381	0.00934	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—Alzheimer's disease	0.00374	0.00917	CbGeAlD
Xylometazoline—ADRA2A—brain—Alzheimer's disease	0.00304	0.00745	CbGeAlD
Xylometazoline—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	9.54e-05	0.000164	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	9.52e-05	0.000164	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	9.48e-05	0.000163	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—F2—Alzheimer's disease	9.48e-05	0.000163	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NOTCH1—Alzheimer's disease	9.47e-05	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	9.46e-05	0.000163	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—Alzheimer's disease	9.45e-05	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	9.44e-05	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	9.43e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	9.42e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	9.39e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF2—Alzheimer's disease	9.39e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	9.38e-05	0.000162	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	9.28e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	9.26e-05	0.00016	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	9.22e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	9.22e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	9.2e-05	0.000159	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF1R—Alzheimer's disease	9.07e-05	0.000156	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	8.96e-05	0.000154	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—TP53—Alzheimer's disease	8.91e-05	0.000154	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CALM1—Alzheimer's disease	8.89e-05	0.000153	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—GSK3B—Alzheimer's disease	8.89e-05	0.000153	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—APOE—Alzheimer's disease	8.86e-05	0.000153	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	8.84e-05	0.000152	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CREB1—Alzheimer's disease	8.82e-05	0.000152	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CALM1—Alzheimer's disease	8.82e-05	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	8.81e-05	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	8.79e-05	0.000152	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—LEP—Alzheimer's disease	8.79e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—APOE—Alzheimer's disease	8.79e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CAV1—Alzheimer's disease	8.78e-05	0.000151	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—INS—Alzheimer's disease	8.77e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	8.76e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	8.76e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	8.75e-05	0.000151	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	8.72e-05	0.00015	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CAV1—Alzheimer's disease	8.71e-05	0.00015	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—GSK3B—Alzheimer's disease	8.71e-05	0.00015	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—LPL—Alzheimer's disease	8.7e-05	0.00015	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CREB1—Alzheimer's disease	8.64e-05	0.000149	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCL2—Alzheimer's disease	8.63e-05	0.000149	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MEF2C—Alzheimer's disease	8.62e-05	0.000149	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	8.6e-05	0.000148	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	8.59e-05	0.000148	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—INS—Alzheimer's disease	8.59e-05	0.000148	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—LPL—Alzheimer's disease	8.59e-05	0.000148	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	8.56e-05	0.000148	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	8.53e-05	0.000147	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IGF1—Alzheimer's disease	8.48e-05	0.000146	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PRKCG—Alzheimer's disease	8.46e-05	0.000146	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCL2—Alzheimer's disease	8.45e-05	0.000146	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ESR1—Alzheimer's disease	8.39e-05	0.000145	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	8.37e-05	0.000144	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	8.34e-05	0.000144	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IGF1—Alzheimer's disease	8.31e-05	0.000143	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—F2—Alzheimer's disease	8.29e-05	0.000143	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NGF—Alzheimer's disease	8.24e-05	0.000142	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	8.14e-05	0.00014	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	8.13e-05	0.00014	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOTCH1—Alzheimer's disease	8.11e-05	0.00014	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	8.06e-05	0.000139	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	8.06e-05	0.000139	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCR5—Alzheimer's disease	8.02e-05	0.000138	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	7.97e-05	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	7.96e-05	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	7.93e-05	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	7.93e-05	0.000137	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	7.86e-05	0.000135	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—Alzheimer's disease	7.84e-05	0.000135	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	7.75e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	7.73e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	7.73e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PPARG—Alzheimer's disease	7.72e-05	0.000133	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NOS3—Alzheimer's disease	7.69e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	7.66e-05	0.000132	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GSK3B—Alzheimer's disease	7.61e-05	0.000131	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	7.57e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—INS—Alzheimer's disease	7.57e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CREB1—Alzheimer's disease	7.55e-05	0.00013	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NOS3—Alzheimer's disease	7.53e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	7.53e-05	0.00013	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	7.51e-05	0.000129	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—INS—Alzheimer's disease	7.51e-05	0.000129	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	7.49e-05	0.000129	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	7.48e-05	0.000129	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	7.44e-05	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	7.41e-05	0.000128	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	7.41e-05	0.000128	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCL2—Alzheimer's disease	7.38e-05	0.000127	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	7.34e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	7.32e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	7.32e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CALM1—Alzheimer's disease	7.32e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APOE—Alzheimer's disease	7.29e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—LEP—Alzheimer's disease	7.29e-05	0.000126	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IGF1—Alzheimer's disease	7.26e-05	0.000125	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TP53—Alzheimer's disease	7.24e-05	0.000125	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CAV1—Alzheimer's disease	7.23e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CALM1—Alzheimer's disease	7.22e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—APOE—Alzheimer's disease	7.2e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	7.18e-05	0.000124	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CAV1—Alzheimer's disease	7.13e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	7.12e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	7.12e-05	0.000123	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	7.07e-05	0.000122	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	6.99e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	6.98e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	6.97e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ESR1—Alzheimer's disease	6.96e-05	0.00012	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—F2—Alzheimer's disease	6.88e-05	0.000118	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	6.87e-05	0.000118	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	6.84e-05	0.000118	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	6.81e-05	0.000117	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	6.8e-05	0.000117	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	6.78e-05	0.000117	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	6.73e-05	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	6.67e-05	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—NOS3—Alzheimer's disease	6.64e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	6.62e-05	0.000114	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	6.59e-05	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	6.58e-05	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	6.55e-05	0.000113	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	6.53e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	6.5e-05	0.000112	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	6.49e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	6.48e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	6.48e-05	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	6.47e-05	0.000112	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.45e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	6.42e-05	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	6.42e-05	0.000111	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CASP3—Alzheimer's disease	6.39e-05	0.00011	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	6.37e-05	0.00011	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL6—Alzheimer's disease	6.35e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	6.33e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	6.32e-05	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PPARG—Alzheimer's disease	6.27e-05	0.000108	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	6.26e-05	0.000108	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	6.23e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	6.23e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	6.18e-05	0.000107	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—INS—Alzheimer's disease	6.15e-05	0.000106	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	6.13e-05	0.000106	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	6.12e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	6.11e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	6.11e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	6.07e-05	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	6.04e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	6.03e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	6.02e-05	0.000104	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	6.02e-05	0.000104	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	6e-05	0.000103	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	5.98e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.98e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	5.96e-05	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	5.94e-05	0.000102	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	5.88e-05	0.000101	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	5.86e-05	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	5.75e-05	9.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	5.68e-05	9.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	5.64e-05	9.72e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	5.61e-05	9.66e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	5.59e-05	9.63e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	5.56e-05	9.59e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.55e-05	9.57e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	5.55e-05	9.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	5.55e-05	9.56e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	5.54e-05	9.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	5.53e-05	9.53e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	5.46e-05	9.41e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	5.44e-05	9.38e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	5.43e-05	9.35e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—NOS3—Alzheimer's disease	5.39e-05	9.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	5.35e-05	9.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	5.21e-05	8.98e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	5.17e-05	8.91e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	5.14e-05	8.86e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	5.14e-05	8.85e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	5.12e-05	8.82e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	5.09e-05	8.77e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	5.09e-05	8.76e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	5.06e-05	8.72e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	5.05e-05	8.69e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	5.01e-05	8.64e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	4.98e-05	8.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	4.97e-05	8.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	4.93e-05	8.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	4.85e-05	8.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	4.76e-05	8.19e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	4.74e-05	8.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	4.71e-05	8.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	4.68e-05	8.07e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.68e-05	8.07e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	4.64e-05	7.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	4.64e-05	7.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	4.62e-05	7.97e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	4.61e-05	7.94e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	4.51e-05	7.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	4.35e-05	7.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	4.33e-05	7.46e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	4.32e-05	7.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	4.28e-05	7.38e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	4.26e-05	7.34e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	4.25e-05	7.32e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	4.19e-05	7.21e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	4.16e-05	7.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	4.12e-05	7.1e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	4.1e-05	7.06e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	4.09e-05	7.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	4e-05	6.89e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	3.94e-05	6.78e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	3.93e-05	6.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.86e-05	6.66e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	3.83e-05	6.6e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	3.83e-05	6.59e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	3.8e-05	6.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	3.79e-05	6.52e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	3.78e-05	6.51e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	3.75e-05	6.46e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	3.67e-05	6.32e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	3.61e-05	6.22e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	3.58e-05	6.17e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	3.54e-05	6.09e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	3.52e-05	6.06e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	3.51e-05	6.04e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	3.5e-05	6.02e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	3.46e-05	5.96e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	3.28e-05	5.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	3.25e-05	5.6e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	3.23e-05	5.57e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	3.21e-05	5.53e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AKT1—Alzheimer's disease	3.05e-05	5.26e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	3.03e-05	5.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	3.02e-05	5.21e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.98e-05	5.14e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	2.97e-05	5.12e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	2.96e-05	5.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	2.77e-05	4.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	2.73e-05	4.71e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	2.72e-05	4.69e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	2.64e-05	4.55e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	2.55e-05	4.4e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	2.51e-05	4.33e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AKT1—Alzheimer's disease	2.48e-05	4.27e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	2.45e-05	4.23e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	2.42e-05	4.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	2.25e-05	3.87e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	2.23e-05	3.84e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	2.07e-05	3.57e-05	CbGpPWpGaD
